Evidence map›Paper›PMID 33707944›Full record

ArticleInternational journal of nanomedicine2021

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.

Xiaoning Lin, Rong Huang, Yanlin Huang, Kai Wang, Heng Li, Yiheng Bao, Chaohui Wu, Yi Zhang, Xinhua Tian, Xiaomin Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Ultrasound- and NIR-Responsive Polydextran/Black TiOACS applied materials & interfaces · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Metal-Doping Strategy for Carbon-Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. [Classification and Application of Ultrasound-Responsive Nanomaterials in Anti-Inflammatory Therapy].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
  14. Advances in Nanodynamic Therapy for Cancer Treatment.Nanomaterials (Basel, Switzerland) · 2024
    Review
  15. Review
  16. Review
  17. Sonocatalytic Optimization of Titanium-Based Therapeutic Nanomedicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  18. A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy.International journal of molecular sciences · 2023
    Review
  19. Recent advances in sonodynamic immunotherapy.Journal of cancer research and clinical oncology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiaoning Lin *Department of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.ORCID 0000-0002-9645-8475
Rong Huang *Department of Child Health, Women and Children's Hospital, Xiamen University, Xiamen, 361003, People's Republic of China.
Yanlin Huang *Department of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Kai WangSchool of Public Health, Xiamen University, Xiamen, 361102, People's Republic of China.
Heng LiDepartment of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Yiheng BaoDepartment of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Chaohui WuDepartment of Thoracic Surgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Yi ZhangDepartment of Breast Surgery, Xiamen TCM Hospital, Xiamen, 361001, People's Republic of China.
Xinhua TianDepartment of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Xiaomin WangFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital Xiamen University, Xiamen, 361004, People's Republic of China.
Zhongshan Hospital of Xiamen University · CNXiamen University · CN174th hospital of the People's Liberation Army · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSonodynamic therapy (SDT) has good targeting and non-invasive advantages in the treatment of solid cancers, and checkpoint blockade immunotherapy is also a promising treatment to cure cancer. However, their antitumor effects are not sufficient due to some inherent factors. Some studies that combined SDT with immunotherapy or nanoparticles have managed to enhance its efficiency to treat cancers.

methodsIn this work, an effective therapeutic strategy that can potentiate the antitumor efficacy of anti-PD-L1 antibody (aPD-L1) is developed by the use of cascade immuno-sonodynamic therapy (immuno-SDT). Titanium dioxide (TiO

resultsThe characterization tests showed that the nanosonosensitizers are polycrystalline structure with homogeneous sizes, resulting in a good drug loading efficiency. The innovative nanosonosensitizers (TiO

conclusionIn this study, we present an effective strategy for tumor treatment by combining nanosonosensitizer-augmented SDT and aPD-L1 checkpoint blockade. This work provides a promising strategy and offers a new vision for treating malignant tumors.

Indexed as

ImmunotherapyUltrasonic TherapyAnimalsCell DeathCell Line, TumorChlorophyllidesCombined Modality TherapyDendritic CellsEndocytosisFemaleHumansImmune Checkpoint InhibitorsImmunityMiceMice, Inbred BALB CMice, Inbred C57BLChlorophyllidesCPG-oligonucleotideImmune Checkpoint InhibitorsOligodeoxyribonucleotidesphytochlorinPorphyrinsReactive Oxygen SpeciesTitaniumtitanium dioxidecancer immunotherapycheckpoint blockadesonodynamic therapysonosensitizertitanium dioxide nanoparticles

Identifiers

PMID33707944
PMCPMC7943542
OpenAlexW3133580632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.